4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol has been researched along with raloxifene in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adrian, MD; Bryant, HU; Cho, S; Cole, HW; Finley, DR; Glasebrook, AL; Godfrey, AG; Grese, TA; Jones, CD; Lugar, CW; Magee, DE; Martin, MJ; Matsumoto, K; Pennington, LD; Phillips, DL; Rowley, ER; Short, LL; Winter, MA | 1 |
Adrian, MD; Bryant, HU; Cole, HW; Fuson, TR; Glasebrook, AL; Grese, TA; Magee, DE; Pennington, LD; Phillips, DL; Rowley, ER; Sato, M; Shetler, PK; Short, LL; Sluka, JP; Venugopalan, M; Yang, NN | 1 |
Dodge, JA; Jones, SA; Lauwers, KS; Wallace, OB | 1 |
Bischoff, SF; Buhl, T; Floersheim, P; Fournier, B; Halleux, C; Kallen, J; Keller, H; Renaud, J; Schlaeppi, JM; Stark, W | 1 |
Bhagwat, SS; Brady, H; Doubleday, M; Gayo, L; Hickman, M; Jalluri, RK; Khammungkhune, S; Kois, A; McKie, JA; Mortensen, D; Richard, N; Sapienza, J; Shevlin, G; Stein, B; Sutherland, M | 1 |
Clegg, NJ; Leitman, DC; Paruthiyil, S; Scanlan, TS | 1 |
Armstrong, MD; Arteaga, CL; Brown, HA; Buck, JR; Cho, HP; Criswell, TL; Lindsley, CW; Scott, SA; Selvy, PE; Thomas, AL | 1 |
Dettmann, S; Gust, R; Müller, CE; Schiedel, A; Szymanowitz, K; Wellner, A | 1 |
Dadiboyena, S | 1 |
Bryant, HU; Chalmers, MJ; Dodge, JA; Griffin, PR; Montrose-Rafizdeh, C; Novick, S; Sato, M; Wang, Y | 1 |
1 review(s) available for 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol and raloxifene
Article | Year |
---|---|
Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator.
Topics: Cell Line, Tumor; Chemistry Techniques, Synthetic; Humans; Isotope Labeling; Organometallic Compounds; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2012 |
9 other study(ies) available for 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol and raloxifene
Article | Year |
---|---|
Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
Topics: Adenocarcinoma; Animals; Binding Sites; Bone and Bones; Breast Neoplasms; Cell Division; Cholesterol; Estrogen Antagonists; Female; Humans; Male; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Uterus | 1997 |
Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
Topics: Animals; Bone Density; Cell Division; Cholesterol; Estrogen Antagonists; Female; Gene Expression Regulation; HeLa Cells; Humans; Models, Molecular; Molecular Conformation; Naphthoquinones; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Transforming Growth Factor beta; Tumor Cells, Cultured; Uterus | 1998 |
Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs).
Topics: Cell Division; Cell Line, Tumor; Humans; Hydroxyquinolines; Inhibitory Concentration 50; Ligands; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Structure-Activity Relationship | 2003 |
Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
Topics: Administration, Oral; Animals; Binding Sites; Biological Availability; Cell Division; Crystallography, X-Ray; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; HeLa Cells; Humans; Isoquinolines; Ligands; Models, Molecular; Radioligand Assay; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Stereoisomerism; Structure-Activity Relationship; Transcription, Genetic; Tumor Cells, Cultured | 2003 |
Lead identification of a potent benzopyranone selective estrogen receptor modulator.
Topics: Animals; Binding Sites; Coumarins; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Interleukin-6; Molecular Structure; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Tumor Cells, Cultured | 2004 |
Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.
Topics: Antineoplastic Agents; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Fluorescence Polarization; Fluorescent Dyes; Genes, Reporter; Humans; Indenes; Ligands; Response Elements; Structure-Activity Relationship | 2005 |
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Topics: Breast Neoplasms; Drug Design; Enzyme Inhibitors; Humans; Isoenzymes; Neoplasm Invasiveness; Phospholipase D | 2009 |
2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Topics: Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor beta; Female; Gene Expression Regulation, Neoplastic; Humans | 2010 |
Hydrophobic Interactions Improve Selectivity to ERα for Ben-zothiophene SERMs.
Topics: | 2012 |